What does Abnova (Taiwan) Corporation do?

Abnova (Taiwan) Corporation (4133.TW) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 4133.TW's market cap?

Abnova (Taiwan) Corporation (4133.TW) has a market capitalization of approximately $1.26 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 4133.TW pay a dividend?

Yes — Abnova (Taiwan) Corporation (4133.TW) pays a dividend annually, with a trailing-twelve-month yield of 0.54%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

Is 4133.TW profitable?

Abnova (Taiwan) Corporation (4133.TW) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

4133.TW

Abnova (Taiwan) Corporation

TAI·Biotechnology · Healthcare

NT$20.80NT$0.05+0.24%

Market capNT$1.26B·Market closed·Aug 26 5:30 AM UTC

Price Chart

NT$20.80+NT$0.05 (+0.24%)today

−56.76%CAGR −15.44%

Select date range

FromTo

Dec 28, 2009Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.54%

Annual Dividend (FWD)NT$0.11

Dividend Growth (5Y)−28.5%

Dividend Safety—

Payout Ratio—

FCF Payout Ratio15.2%

Most Recent DividendNT$0.112

Ex-Dividend DateJun 16

Payment DateJul 8

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)−10.1%

EPS Growth (5Y)+1.7%

Next Earnings DateMay 22

Last Report DateJun 30

Reported vs Estimate−NT$0.60

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$345.45M

Net IncomeNT$44.87M

Net Margin13.0%

Operating Cash FlowNT$51.47M

Capital ExpendituresNT$6.71M

Free Cash FlowNT$44.76M

Return on Equity3.5%

Return on Invested Capital0.4%

Net CashNT$389.10M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 4133.TW and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 4133.TW's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4133.TW and 80,000+ other tickers.

About Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation specializes in the development and distribution of a comprehensive range of recombinant proteins and antibodies. The company's extensive product portfolio caters to diverse research and diagnostic applications, featuring specialized reagents for SARS-CoV/CoV-2, nucleic acids (both DNA and RNA), and various proteins and peptides. Their offerings further include items like DNAxPab, laboratory beads, dyes, cellular lysates, microscopic slides, antibody pairs and associated kits, as well as antibody and tissue arrays. Additionally, they provide in situ hybridization…

CEO: Peiru Ji
Sector: Healthcare
Industry: Biotechnology
Exchange: TAI
Employees: 110
Website: www.abnova.com.tw

Peers

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 4133.TW

What does Abnova (Taiwan) Corporation do?: Abnova (Taiwan) Corporation (4133.TW) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 4133.TW's market cap?: Abnova (Taiwan) Corporation (4133.TW) has a market capitalization of approximately $1.26 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 4133.TW pay a dividend?: Yes — Abnova (Taiwan) Corporation (4133.TW) pays a dividend annually, with a trailing-twelve-month yield of 0.54%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.
Is 4133.TW profitable?: Abnova (Taiwan) Corporation (4133.TW) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.